PVLA
Palvella Therapeutics
PVLA
PVLA
99 hedge funds and large institutions have $534M invested in Palvella Therapeutics in 2025 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 24 increasing their positions, 20 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
23.63% more ownership
Funds ownership: 53.45% → 77.09% (+24%)
20% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 20
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
99
Holding in Top 10
1
Calls
$984K
Puts
$320K
Top Buyers
| 1 | +$33.9M | |
| 2 | +$29.1M | |
| 3 | +$24.8M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$21.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$20.7M |
Top Sellers
| 1 | -$18.1M | |
| 2 | -$8.16M | |
| 3 | -$6.74M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$6.26M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$2.92M |
